These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 11762051

  • 1. [Prevention of hepatocellular carcinogenesis by interferon].
    Ikeda K.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
    [No Abstract] [Full Text] [Related]

  • 2. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H, Omata M.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S, Kubo S, Shiomi S.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract] [Full Text] [Related]

  • 4. [Retinoid].
    Moriwaki H.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():764-8. PubMed ID: 11762053
    [No Abstract] [Full Text] [Related]

  • 5. [Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related chronic hepatitis and cirrhosis].
    Kasahara A, Hiramatsu N.
    Nihon Rinsho; 2011 May; 69 Suppl 4():314-8. PubMed ID: 22096937
    [No Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma.
    Desjardins LA.
    Clin J Oncol Nurs; 2002 May; 6(2):107-8. PubMed ID: 11889672
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome after interferon therapy in patients with chronic hepatitis C.
    Buti M, Esteban R.
    Ann Hepatol; 2007 May; 6(4):267-9. PubMed ID: 18007558
    [No Abstract] [Full Text] [Related]

  • 8. [Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
    Tarao K.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():769-73. PubMed ID: 11762054
    [No Abstract] [Full Text] [Related]

  • 9. [The natural history of HCV infection: the role of interferon therapy].
    Rumi MG, Romeo R.
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):119-22. PubMed ID: 7542482
    [No Abstract] [Full Text] [Related]

  • 10. [High risk group for development of hepatocellular carcinoma].
    Koike Y, Shiratori Y.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract] [Full Text] [Related]

  • 11. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H, Iga D, Arisaka Y, Mitsuhashi Y, Kamitsukasa H, Yagura M, Endou H, Kawashima H.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract] [Full Text] [Related]

  • 12. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T, Mima S.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract] [Full Text] [Related]

  • 13. [Interferon therapy to chronic hepatitis type C for the prevention of hepatocarcinogenesis].
    Ichida T, Ohkoshi S, Takimoto M, Ishikawa T.
    Nihon Rinsho; 2001 Jul; 59(7):1331-7. PubMed ID: 11494547
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A, Jabbour N.
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract] [Full Text] [Related]

  • 15. Causes of and prevention strategies for hepatocellular carcinoma.
    Cabibbo G, Maida M, Genco C, Antonucci M, Cammà C.
    Semin Oncol; 2012 Aug; 39(4):374-83. PubMed ID: 22846856
    [Abstract] [Full Text] [Related]

  • 16. The epidemiology of hepatocellular carcinoma.
    Johnson PJ.
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
    [Abstract] [Full Text] [Related]

  • 17. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E, Kaneko S, Kobayashi K.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of hepatocellular carcinoma.
    Kew MC.
    S Afr J Surg; 2011 Apr; 49(2):50-1, 86. PubMed ID: 21614973
    [No Abstract] [Full Text] [Related]

  • 19. [Interferon treatment for aged patients with hepatitis C].
    Hiramatsu N, Kasahara A, Hayashi N, Imai Y.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):640-4. PubMed ID: 15359876
    [No Abstract] [Full Text] [Related]

  • 20. [Risk factors and prevention of hepatocellular carcinoma].
    Tanaka K.
    Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.